Replimune Group, Inc. (REPL)

7.905 +0.64 (+8.88%) USD  |  NASDAQ  |  Jan 22, 16:00
7.905 0.00 (0.00%) After-Hours: 20:00
More

Replimune Group Net Income (Quarterly)

Net Income (Quarterly) Chart

View Net Income (Quarterly) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Income (Quarterly) Range, Past 5 Years

View Net Income (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Quarterly) Benchmarks

View Net Income (Quarterly) Benchmarks
Start Trial
Rapt Therapeutics, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade
Anavex Life Sciences Corp. Upgrade